Product namePrice SuppliersUpdate time Aripiprazole $76.00/200mg VIP5Y TargetMol Chemicals Inc. 2024-11-19 Aripiprazole $0.00/25KG VIP5Y Hebei Mojin Biotechnology Co., Ltd 2024-10-23 Aripiprazole $0.00/1g VIP1Y BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD. 2024-09-05 Aripiprazole $0.0...
Aripiprazole price More Price(60) ManufacturerProduct numberProduct description CAS numberPackagingPriceUpdated Buy Sigma-Aldrich PHR1784 Aripiprazole solution 129722-12-9 500mg $267 2024-03-01 Buy Sigma-Aldrich A-119 Aripiprazole solution 1.0?mg/mL (50:50 Methanol/Water with 1% 1N HCl), ampule...
Matsubayashi H, Amano T, Sasa M. Inhibition by aripiprazole of dopaminergic inputs to striatal neurons from substantia nigra. Psychopharmacology (Berl) 1999 Sep; 146(2): 139–43 Ishii D, Matsuzawa D, Kanahara N, et al. Effects of aripiprazole on MK-801-induced prepulse inhibition deficits a...
▴ In two large, well-designed trials in patients with MDD who had an inadequate response to standard antidepressant therapy, 6 weeks’ adjunctive therapy with aripiprazole 2–20 mg/day improved mean Montgomery Asberg Depression Rating Scale (MADRS) total scores (primary endpoint) to a significant...
Kessler RM, Mason N, Jones C, Ansari MS, Manning RF, Price RR (2000). [18F]N-allyl-5-fluoropropylepidepride (fallypride): ra- diation dosimetry, quantification of striatal and extrastriatal dopamine receptors in man. NeuroImage 11: S32. Kikuchi T, Tottori K, Uwahodo Y, Hirose T, ...
▴ In patients with acute relapse of schizophrenia or schizoaffective disorder, aripiprazole 15 to 30 mg/day was at least as effective as haloperidol 10 mg/day and had similar efficacy to risperidone 6 mg/day in well designed, 4-week, placebo-controlled trials. ▴ Negative symptoms improve...
Single (1.0mg/kg) and repeated (0.03 and 0.1mg/kg, for 7days) treatment with aripiprazole ameliorated PCP-induced impairment of recognition memory, although single treatment significantly decreased the total exploration time during the training session. In contrast, both single and repeated treatment ...
Aripiprazole [3.22 (1.9) mg/day] decreased tic score as much as risperidone [0.6 (0.2) mg/day]. Their adverse effects and their effects on health related quality of life were comparable. However, risperidone increased the patients’ social functioning more than aripiprazole in short term. This...